Faculty profile
Jonathan Angel
Back to facultyResearch
Read how they describe their research on their University of Ottawa profile.
Latest papers
Safety of multiple administrations of spermicidal LL-37 antimicrobial peptide into the mouse female reproductive tract.
Molecular human reproduction · 2023
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286).
Patient preference and adherence · 2022
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota.
Open forum infectious diseases · 2020
Latest funding
- $20,000
HIV Vaccines: Search for a Cure
CIHR · 2024 · Nominated PI
- $20,000
Reality Check: HIV Vaccine Failures, Progress and the Way Forward
CIHR · 2023 · Nominated PI
- $15,000
HIV Vaccines: Taking Stock
CIHR · 2022 · Nominated PI
6 publications.
Safety of multiple administrations of spermicidal LL-37 antimicrobial peptide into the mouse female reproductive tract.
Lee SG, Kiattiburut W, Burke Schinkel SC, Angel J, Tanphaichitr N
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286).
Klein MB, Young J, Ortiz-Paredes D, Wang S, Walmsley S, Wong A, Martel-Laferrière V, Pick N, Conway B, Angel J, Baril JG, Fraser C, Lebouché B, Tan DHS, Sandre R, Trottier S, Peiris H, Jayaraman J, Singer J, CTN 286 Study Investigators
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota.
Isnard S, Lin J, Fombuena B, Ouyang J, Varin TV, Richard C, Marette A, Ramendra R, Planas D, Raymond Marchand L, Messaoudene M, Van der Ley CP, Kema IP, Sohail Ahmed D, Zhang Y, Finkelman M, Routy B, Angel J, Ancuta P, Routy JP
cIAP1/2-TRAF2-SHP-1-Src-MyD88 Complex Regulates Lipopolysaccharide-Induced IL-27 Production through NF-κB Activation in Human Macrophages.
Busca A, Konarski Y, Gajanayaka N, O'Hara S, Angel J, Kozlowski M, Kumar A
An HIV-tailored quit-smoking counselling pilot intervention targeting depressive symptoms plus Nicotine Replacement Therapy.
Balfour L, Wiebe SA, Cameron WD, Sandre D, Pipe A, Cooper C, Angel J, Garber G, Holly C, Dalgleish TL, Tasca GA, MacPherson PA
PI3K/Akt regulates survival during differentiation of human macrophages by maintaining NF-κB-dependent expression of antiapoptotic Bcl-xL.
Busca A, Saxena M, Iqbal S, Angel J, Kumar A
HIV Vaccines: Search for a Cure
Principal investigators: Angel, Jonathan B
Keywords: Hiv; Knowledge Dissemination; Vaccine; Virology
Reality Check: HIV Vaccine Failures, Progress and the Way Forward
Principal investigators: Angel, Jonathan B
Keywords: Hiv; Vaccines; Virology
HIV Vaccines: Taking Stock
Principal investigators: Angel, Jonathan B
Keywords: Hiv; Vaccines
COVID-19 Variant Supplement - Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals
Principal investigators: Bell, John C; Ilkow, Carolina S; Lapointe, Réjean; Mahoney, Douglas J
Keywords: Covid-19; Epitopes; Immunity; Infection; Manufacturing; Pre-Clinical; Sars-Cov-2; Vaccine
A Pilot Feasibility Study to Inform the Development of a Novel Clinical and Biomarker-driven Definition of COPD Exacerbation among Hospitalized Adults in Canada
Principal investigators: Mulpuru, Sunita
Keywords: Biomarkers; Copd; Exacerbations; Feasibility Study
Use of antimicrobial peptides, LL-37/17BIPHE2, as vaginal spermicides/microbicides as part of multipurpose prevention technology (MPT)
Principal investigators: Tanphaichitr, Nongnuj; Angel, Jonathan B; Gadde, Suresh; Sheth, Prameet M
Keywords: Antimicrobial Peptide; Contraceptive; Hiv; Ll-37; Microbicide; Nanoparticle; Neisseria Gonorrhoeae; Spermicide; Vagina; Vaginal Microbiome
Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals
Principal investigators: Bell, John C; Ilkow, Carolina S; Lapointe, Réjean; Mahoney, Douglas J
Keywords: Covid-19; Epitopes; Immunity; Infection; Manufacturing; Pre-Clinical; Sars-Cov-2; Vaccine
HIV Vaccines: Progress, Failures and New Directions
Principal investigators: Angel, Jonathan B; Grant, Michael D
Keywords: Health Research; Hiv; Knowledge Translation; Vaccine
HIV Vaccines: Where do we go next?
Principal investigators: Angel, Jonathan B
Keywords: Health Research; Hiv; Knowledge Translation; Vaccine
The Road Ahead: HIV Vaccines
Principal investigators: Angel, Jonathan B; Grant, Michael D
Keywords: Education; Hiv; Knowledge Dissemination; Vaccines
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Biochemistry, Microbiology and Immunology
- Pathology and Laboratory Medicine
- Department of Medicine
- Family Medicine
- Hematology-Oncology
- Microbiology and Immunology
- Medicine
- Other
Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Ashok Kumar
Pathology and Laboratory Medicine
2 shared papers, latest 2018
Curtis Cooper
Department of Medicine
1 shared papers, latest 2017
Jean-Pierre Routy
Medicine
1 shared papers, latest 2020
Jean-Pierre Routy
Microbiology and Immunology
1 shared papers, latest 2020
Nongnuj Tanphaichitr
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2023
Sharon Walmsley
School of Population and Public Health
1 shared papers, latest 2022
Sharon Walmsley
Infectious Diseases
1 shared papers, latest 2022
Bertrand Routy
Hematology-Oncology
1 shared papers, latest 2020
Andrew Pipe
Family Medicine
1 shared papers, latest 2017
Neora Pick
Pathology and Laboratory Medicine
1 shared papers, latest 2022
Gary Garber
Department of Medicine
1 shared papers, latest 2017
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.